Opportunity Information: Apply for RFA IP 14 002
Apply for RFA IP 14 002
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in a Malaria Endemic Area of Malawi with High HIV Prevalence" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.083 Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases.
- This funding opportunity was created on Nov 14, 2013 and posted on Nov 14, 2013.
- Applicants must submit their applications by Jan 13, 2014 Application Due Date January 13, 2014 by 500 PM U.S. Eastern Time.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,200,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Organizations University of Liverpool, Liverpool School of Tropical Medicine, Malawi Liverpool Wellcome Trust Clinical Research Programme, Pembroke Place, Liverpool L3 5QA, UK
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (Funding Opportunity Number RFA IP 14 002) was a CDC Centers for Disease Control and Prevention discretionary funding announcement under the National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division. It was structured as a cooperative agreement, meaning CDC expected to have substantial involvement in the work alongside the recipient rather than simply providing funds with minimal federal interaction. The public health focus was on improving the ability to detect, describe, and study influenza along with other emerging and re-emerging respiratory infectious diseases in Malawi, with particular attention to the real-world context of a malaria-endemic setting and a population with high HIV prevalence. In addition to surveillance and epidemiology, the project aimed to support evaluations of new or improved diagnostics, vaccines, and other interventions that could prevent or treat influenza and related respiratory infections in this high-burden environment.
The announcement anticipated making one award, with an estimated total funding amount of 5,000,000. The stated award ceiling was 1,200,000 and the floor was 100,000, and there was no cost sharing or matching requirement. The assistance listing (CFDA) associated with the opportunity was 93.083, described as Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases, which aligns with influenza and broader respiratory disease control priorities.
Eligibility was not open broadly; it was effectively a targeted or restricted competition. The eligible applicant was specifically identified as the University of Liverpool, Liverpool School of Tropical Medicine, operating through the Malawi Liverpool Wellcome Trust Clinical Research Programme (with the listed address in Liverpool, UK). In practical terms, this meant the CDC was seeking to partner with an established research and clinical platform already working in Malawi, likely because of existing infrastructure, local collaborations, and the capacity to conduct field-based surveillance and studies in the relevant communities and health facilities.
Key dates show this is an archived funding opportunity rather than an active one. The posting and creation date were November 14, 2013. Applications were due January 13, 2014 by 5:00 PM U.S. Eastern Time, and the archive date was February 12, 2014. For applicants or researchers looking back at the opportunity, the listing included a note directing users to the "Full Announcement" area for complete details, and provided a CDC Procurement and Grants Office contact (Technical Information Management Section) for help accessing the full announcement.
Overall, the opportunity was designed to strengthen Malawi-based capacity across several linked areas: respiratory disease detection and characterization, applied epidemiologic studies in a setting complicated by malaria and high HIV prevalence, and evaluation of tools like diagnostics, vaccines, and other interventions. The intent was not only to generate data on influenza and other respiratory threats, but also to support practical, evidence-generating work that could guide prevention and treatment approaches in Malawi and contribute to broader global understanding of respiratory infections in similarly complex, high-burden settings.
Frequently Asked Questions (FAQ)
What is the funding opportunity number for this grant?
The funding opportunity number is RFA IP 14 002.
Which federal agency offered this grant opportunity?
This opportunity was offered by the U.S. Centers for Disease Control and Prevention (CDC).
Which CDC center/division managed the opportunity?
It was issued under CDC's National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division.
What type of funding mechanism was used?
The award mechanism was a cooperative agreement. That means CDC anticipated substantial involvement in the work alongside the recipient, rather than providing funds with minimal federal interaction.
What public health focus did the project support?
The project focused on improving the ability to detect, describe, and study influenza, along with other emerging and re-emerging respiratory infectious diseases, in Malawi.
What country and setting were emphasized in this opportunity?
The work was centered in Malawi, with particular attention to real-world conditions in a malaria-endemic environment and a population with high HIV prevalence.
Beyond surveillance, what kinds of activities were included in the scope?
In addition to surveillance and epidemiology, the project aimed to support evaluations of new or improved diagnostics, vaccines, and other interventions to prevent or treat influenza and related respiratory infections in a high-burden setting.
How many awards did CDC expect to make?
The announcement anticipated making one award.
What was the estimated total funding amount?
The estimated total funding amount was 5,000,000.
What were the award ceiling and floor?
The stated award ceiling was 1,200,000 and the floor was 100,000.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement stated for this opportunity.
What Assistance Listing (CFDA) number was associated with this opportunity?
The associated Assistance Listing (CFDA) number was 93.083.
What is CFDA 93.083 described as?
It was described as: "Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases."
Who was eligible to apply?
Eligibility was restricted. The eligible applicant was specifically identified as the University of Liverpool, Liverpool School of Tropical Medicine, operating through the Malawi Liverpool Wellcome Trust Clinical Research Programme.
Was this an open competition?
No. It was effectively a targeted or restricted competition rather than broadly open eligibility.
Where was the listed eligible applicant located?
The listing indicated an address in Liverpool, UK for the eligible applicant entity.
When was the opportunity posted?
The posting and creation date were November 14, 2013.
When were applications due?
Applications were due January 13, 2014 by 5:00 PM U.S. Eastern Time.
Is this funding opportunity still active?
No. This is an archived funding opportunity.
When was the opportunity archived?
The archive date was February 12, 2014.
What should someone do if they need complete details that were not in the listing summary?
The listing directed users to the "Full Announcement" area for complete details.
Who was listed as a contact for help accessing the full announcement?
A CDC Procurement and Grants Office contact was provided: the Technical Information Management Section, for assistance with accessing the full announcement.
What capacity-building outcomes was the opportunity designed to support in Malawi?
The opportunity was designed to strengthen Malawi-based capacity across linked areas, including respiratory disease detection and characterization, applied epidemiologic studies in a malaria-endemic and high-HIV-prevalence setting, and evaluation of tools such as diagnostics, vaccines, and other interventions.
What broader purpose did the project serve besides generating local data?
The intent included supporting practical, evidence-generating work to guide prevention and treatment approaches in Malawi and to contribute to broader global understanding of respiratory infections in similarly complex, high-burden settings.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: R3 Wildlife Restoration Grant Program (TO STATE FG AGENCIES ONLY)
Previous opportunity: R3 Sport Fish Restoration Grant Program (TO STATE FG AGENCIES ONLY)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 14 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 14 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing Patient Safety Implementation through Safe Medication Use Research (R18) Apply for PA 14 002 Funding Number: PA 14 002 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Collaborative Activities to Promote Metabolomics Research (Admin Supp) Apply for PA 14 003 Funding Number: PA 14 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Health Network Development Planning Program Apply for HRSA 14 043 Funding Number: HRSA 14 043 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| ATSDRs Program to Promote Localized Efforts To Reduce Environmental Exposure (APPLETREE) Apply for CDC RFA TS14 1403 Funding Number: CDC RFA TS14 1403 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| The Cooperative Re Engagement Controlled Trial (CoRECT) Apply for RFA PS 14 001 Funding Number: RFA PS 14 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,300,000 |
| Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria Endemic Countries Apply for RFA CK 14 004 Funding Number: RFA CK 14 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Service Area Competition Additional Area (SAC AA) Evergreen, AL Gualala, CA Tallahassee, FL Nashua, NH Waxahachie, Texas and Kenosha, WI Apply for HRSA 14 111 Funding Number: HRSA 14 111 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Advances in Patient Safety through Simulation Research (R18) Apply for PA 14 004 Funding Number: PA 14 004 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Continuum of Prevention, Care and Treatment of HIV/AIDS in Most at Risk Poupulations in Cameroon CHAMP Apply for RFA 624 14 000001 Funding Number: RFA 624 14 000001 Agency: Ghana USAID Accra Category: Health Funding Amount: $18,800,000 |
| Animal and Biological Material Resource Centers (P40) Apply for PAR 14 005 Funding Number: PAR 14 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Safety Learning Laboratories Innovative Design and Development to Improve Healthcare Delivery Systems (P30) Apply for RFA HS 14 005 Funding Number: RFA HS 14 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $1,000,000 |
| National Training and Technical Assistance Cooperative Agreements (NCAs) Apply for HRSA 14 031 Funding Number: HRSA 14 031 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Secondary Data Analyses to Explore NIMH Research Domain Criteria (R03) Apply for PAR 14 008 Funding Number: PAR 14 008 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01) Apply for PAR 14 009 Funding Number: PAR 14 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics Data Coordinating Center (DCC) (U01) Apply for RFA HL 14 030 Funding Number: RFA HL 14 030 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics Clinical Centers (CC) (U01) Apply for RFA HL 14 027 Funding Number: RFA HL 14 027 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Indoor Environment of Low Income Renovated Multifamily Housing in the United States (U01) Apply for RFA EH 14 001 Funding Number: RFA EH 14 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Increasing Participation of People with Disabilities in USAID Activities and Strengthen the Capacities of Disabled Peoples Organizations (DPOs). Apply for RFA 114 14 000001 Funding Number: RFA 114 14 000001 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Deliberative Approaches Patient and Consumer Input for Implementing Evidence Based Health Care (R21) Apply for RFA HS 14 007 Funding Number: RFA HS 14 007 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $200,000 |
| International Collaborations in Infectious Diseases Research (U01) Apply for RFA AI 14 001 Funding Number: RFA AI 14 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 14 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.